|1.||Johansson, S G O: 8 articles (07/2012 - 04/2005)|
|2.||Florvaag, E: 8 articles (07/2012 - 04/2005)|
|3.||Oman, H: 4 articles (05/2009 - 04/2005)|
|4.||Clarke, Russell C: 2 articles (10/2014 - 07/2014)|
|5.||Platt, Peter R: 2 articles (10/2014 - 07/2014)|
|6.||Brusch, Anna M: 2 articles (10/2014 - 07/2014)|
|7.||Florvaag, Erik: 2 articles (04/2014 - 03/2010)|
|8.||Demoly, Pascal: 2 articles (08/2012 - 06/2011)|
|9.||Nopp, A: 2 articles (05/2009 - 01/2006)|
|10.||Harboe, T: 2 articles (12/2007 - 01/2006)|
11/01/2015 - "Is pholcodine a dangerous cough suppressant?"
03/01/2013 - "Pholcodine is an opioid that has been widely used worldwide since 1950 for the treatment of non-productive cough in children and adults. "
03/01/2013 - "[New insights into the role of pholcodine in the treatment of cough in 2013?]."
05/01/2012 - "The search for a substance inducing sensitization to muscle relaxants has led Norwegian and Swedish scientists to pholcodine, a cough suppressant, which is widely used in Europe and worldwide. "
08/01/2009 - "Eventually, a cough syrup containing pholcodine emerged as the most likely suspect. "
|2.||Anaphylaxis (Anaphylactic Shock)
05/01/2012 - "Based on the results of published studies that pointed to a connection of the use of pholcodine and perioperative anaphylactic reaction, pholcodine was withdrawn from the Norwegian market and subsequent research revealed a reduction of anaphylactic reactions in that country. "
10/01/2014 - "Response to letter regarding article 'Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis'."
10/01/2014 - "Letter to the authors concerning the accepted manuscript: exploring the link between pholcodine and neuromuscular anaphylaxis by Brush et al."
07/01/2014 - "This link has prompted the withdrawal of pholcodine in some countries, with an ensuing fall in the observed rate of NMBA anaphylaxis. "
07/01/2014 - "Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis."
11/01/2014 - "Stability of a 1.0 mg ml(-1) aqueous pholcodine solution for allergy skin testing."
07/01/2014 - "This review aims to explore the evidence linking pholcodine exposure to NMBA hypersensitivity and discuss the implications for our understanding of the pathophysiology of these reactions. "
07/01/2014 - "While such observations are compelling in their suggestion of a relationship between pholcodine exposure and NMBA hypersensitivity, important questions remain regarding the mechanisms by which pholcodine is able to sensitize against NMBAs and whether there are other, as yet unidentified, agents that can elicit similar hypersensitivity reactions. "
08/01/2012 - "A recent hypothesis concerning a link between pholcodine exposure and allergic reactions to NMBAs is under investigation. "
06/01/2011 - "Even though the 'pholcodine hypothesis' has been suggested to explain the occurrence of NMBA-induced allergy, this concept remains unclear. "
|4.||Substance-Related Disorders (Drug Abuse)
01/01/1995 - "Finally, in an epidemiological survey of drug addict behaviors and detection of drug addiction, it seems very difficult, may be even illusory and hazardous, to try and justify morphine found in urines (morphine, heroin, codeine, codethyline, pholcodine...) except in the very legitimate case where the ratio of urine concentrations of codeine and morphine is greater than one."
|2.||Immunoglobulin E (IgE)
|3.||Morphine (MS Contin)
|4.||Neuromuscular Blocking Agents
|5.||Succinylcholine (Suxamethonium Chloride)
|8.||Quaternary Ammonium Compounds (Ammonium)